Provided by Tiger Fintech (Singapore) Pte. Ltd.

Silence Therapeutics Plc

6.17
+0.01000.16%
Post-market: 6.170.00000.00%19:47 EDT
Volume:62.30K
Turnover:383.94K
Market Cap:291.41M
PE:-4.06
High:6.28
Open:6.09
Low:6.07
Close:6.16
Loading ...

European Equities Traded in the US as American Depositary Receipts Marginally Higher in Monday Trading

MT Newswires Live
·
05 May

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading

MT Newswires Live
·
28 Apr

New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis

GlobeNewswire
·
26 Apr

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

3 Promising Penny Stocks With Market Caps Under $200M

Simply Wall St.
·
17 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
14 Apr

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading

MT Newswires Live
·
11 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
07 Apr

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It. -- Barrons.com

Dow Jones
·
07 Apr

European Equities Traded in the US as American Depositary Receipts Plunge in Friday Trading

MT Newswires Live
·
04 Apr

Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences’ DecisionDx®-Melanoma Test

GlobeNewswire
·
03 Apr

Silence Therapeutics plc (NASDAQ:SLN): When Will It Breakeven?

Simply Wall St.
·
02 Apr

Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma

GlobeNewswire
·
02 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Castle Biosciences' DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups

GlobeNewswire
·
29 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading

MT Newswires Live
·
13 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT Newswires Live
·
08 Mar

New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences' Dermatology Portfolio

Business Wire
·
07 Mar